Keywords: merck, co, refile, arcoxia, nda, said, its

Merck & Co will refile Arcoxia NDA in 2003

Article | 17 June 2002

Print This

Merck & Co has said that it will refile its New Drug Application inthe USA for Arcoxia (etoricoxib), a follow-up drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in